综合性批量和单细胞转录组学将EZH2与免疫抑制计划和瘤-Treg交叉对抗割的前列腺癌的交叉链接
Xing Xiong1, Jianhu Xie1, Ping Dai1
1Department of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Frontiers in immunology
|February 19, 2026
概括
增强血清同源2 (EZH2) 驱动前列腺癌的进展和免疫功能障碍. 抑制EZH2可能会恢复抗瘤免疫力,为晚期前列腺癌提供新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 在前列腺癌 (PCa) 中,增强性雌激素同源2 (EZH2) 的增强剂被上调调节,特别是在致命的抵抗割的前列腺癌 (CRPC) 中.
- 先进的PCa表现出严重的免疫功能障碍,EZH2在相关免疫程序中的作用尚未完全理解.
- 在批量和单细胞数据中对EZH2相关的免疫程序进行系统的划分,对于先进的PCa缺乏.
研究的目的:
- 在PCa中绘制EZH2相关的转录和免疫特征,使用集成的多omics数据.
- 描述晚期PCa中特定于细胞类型的EZH2功能,包括它对恶性细胞和瘤微环境的影响.
- 研究CRPC中EZH2抑制的治疗潜力.
主要方法:
- 从PCa队列中大量RNA-seq和单细胞RNA测序 (scRNA-seq) 数据的综合分析.
- 在批量队列中量化EZH2表达,临床结果和免疫特征丰富.
- scRNA-seq分析以描述恶性细胞和免疫子集中的EZH2表达,并推断瘤-免疫细胞通信.
- 在CRPC细胞系中对EZH2抑制剂tazemetostat进行体外评估.
主要成果:
- 在批量队列中,较高的EZH2表达与不良临床结果和免疫抑制特征 (Treg,TAM) 相相关.
- 免疫调节差异表达基因 (IMDEGs) 定义了具有独特免疫状态和预后价值的患者子组.
- 在CRPC恶性细胞中增加的EZH2与增殖和免疫基因表达的减少有关;EZH2也在Tregs中增加.
- 在实验室中,塔泽美托斯治疗降低了H3K27me3和调高了免疫和炎症相关基因.
结论:
- 在先进的PCa中,EZH2促进增殖性恶性状态和免疫抑制性瘤微环境,涉及Treg交叉声.
- 抑制EZH2显示了调节这些程序的潜力,这表明了针对高级PCa的EZH2向疗法.
- 需要进一步研究以阐明EZH2在PCa进展和免疫逃避中的功能和因果机制.
相关概念视频
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


